Table 1.
Number, age, sex and cardiovascular metabolic diseases of patients of the 6 included studies
| References | Date | Number of patients | Hospital | Age | Sex (male, %) | Cardiovascular metabolic diseases | |||
|---|---|---|---|---|---|---|---|---|---|
| Hypertension (%) | Diabetes (%) | Cardia-cerebrovascular disease (%) | Cardiac injury (%) | ||||||
| Wang et al. [5] | 2020.01.01–2020.01.28 | 138 | Zhongnan Hospital | 56 (42–68) | 54.3 | 31.2 | 10.1 | 19.6 | 7.2 |
| Huang et al. [4] | 2019.12.16–2020.01.02 | 41 | Jinyintan Hospital | 49 (41–58) | 73 | 15 | 20 | 15 | 12 |
| Guan et al. [8] | As of 2020.01.29 | 1099 | 552 hospitals in China | 47 (35–58) | 59.2 | 14.9 | 7.4 | 3.9 | 13.7* |
| Chen et al. [6] | 2020.01.01–2020.01.28 | 99 | Jinyintan Hospital | 55.5 (21–82) | 68 | – | 12 | 40 | 13* |
| Chang et al. [16] | 2020.01.16–2020.02.04 | 11 | 3 hospitals in Beijing | 34 (34–48) | 77 | – | – | – | – |
| Liu et al. [17] | 2019.12.30–2020.01.24 | 137 | 9 tertiary hospitals in Hubei | 57 (20–83) | 44.5 | 9.5 | 10.2 | 7.3 | – |
In the two studies, 13(13%) and 90 (13.7) patients were reported as elevation of creatine kinase, but they were not confirmed as cardiac injury